Search - tctmd.com

Displaying 741 - 760 of 1914

Sort: Relevancy | Date

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

May 31, 2018

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

News Conference News EuroPCR 2018

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Yael L. Maxwell

May 30, 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

May 24, 2018

“Transient” STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Podcast TCTMD Talking Points

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

May 23, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

May 09, 2018

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

News Daily News

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Michael O'Riordan

May 07, 2018

Some Sex Differences Disappear With an Improved STEMI Protocol

News Daily News

Some Sex Differences Disappear With an Improved STEMI Protocol

May 07, 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

May 04, 2018

Alirocumab Price Slashed in Deal With Express Scripts

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

News Daily News

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

May 02, 2018

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

News Daily News

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

May 01, 2018

Seattle Angina Questionnaire Works Equally Well in Women

News Daily News

Seattle Angina Questionnaire Works Equally Well in Women

Michael O'Riordan

April 30, 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

News Conference News SCAI 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

April 27, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.